RPS6KB1 and breast cancer: PF-4708671 inhibits S6K1, the most downstream kinase in the mTOR pathway, to inhibit BC cell migration in a triple-negative BC metastasis model and thus may provide an effective adjuvant treatment against BC metastasis (58).